Kennedy-Enzi Hearing


The witness roster for the peculiarly timed Senate Committee on Health, Education, Labor and Pensions entitled "Building a 21st Century FDA:  Proposals to Improve Drug Safety and Innovation" has been filled.  The hearing will occur November 16, Thursday at 10 AM in Room 430 of the Dirksen Senate Office Building. 

Panel I

  • Ms. Sheila Burke, co-Chair, Committee on the Assessment of the U.S. Drug Safety System, Institute of Medicine, Washington, D.C.

Panel II

  • Ms. Diane Thompson, Vice President, Public Policy and Communications, Elizabeth Glaser Pediatric AIDS Foundation, Washington, D.C.
  • Dr. Steven Nissen, Chairman, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
  • Dr. Adrian Thomas, Vice President, Benefit-Risk Management, Johnson & Johnson Pharmaceutical Group, Horsham, PA
  • Mr. Jim Guest, President & CEO, Consumers Union, Yonkers, New York
  • Mr. Greg Simon, President, FasterCures, Washington, D.C.

Note that Dr. Steven Nissen, an FDA Advisory Committee member, was a key figure in assessing risk associated with COX-2s during the special advisory committee meetings held in relation to that class of drugs. 

This entry was posted in Current Affairs. Bookmark the permalink.